Description:
CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company is headquartered in Vienna, Virginia.
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
8229 BOONE BLVD ., SUITE 802, VIENNA, VA, US
Fiscal year end:
September
Market capitalization:
$59.3 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-98%
How much will you get:
$17
Prices dates:
31-07-2015: $472.58 and 31-07-2025: $8.18